SBIR/STTR Research Award

Novel Protecting Group Chemistry for Nucleic Acids

Award identifier 31e3052efd0921f9fc94d47a0da71761e22c3ccc5e4d1f2a02e16af9029d11b8Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$140,641

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOLINK PARTNERS
Proposal award date
Not reported
Contract end date
Not reported
UEI
DT57BJUXHNW3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Thermolabile protecting groups of nucleic acids which can be removed during genomic methods will be developed. Protecting groups for nucleobase substituents involved in Watson-Crick hydrogen bonding will be identified and used to block hybridization. Subsequent removal of the thermolabile group at elevated temperature for 10-30 minutes, and as part of the genomic method, will release the desired nucleic acid and allow the genomic method to be initiated under controlled conditions of time and temperature. The technology is expected to eliminate non-specific reactions and false readings caused by mis-matched hybrids, primers annealed to non-target template, mis-priming, and partially complementary primers at ambient temperature. The primary objective is to prevent premature or erroneous formation of hybridized nucleic acids during sample preparation procedures that lead to undesirable events of sequence recognition. The specific aims are (1) development of chemistry for reversible, thermolabile, covalent modification of nucleic acids and (2) preparation and characterization of modified nucleic acids suitable for specific genomic methods. Nucleosides and small nucleotides will be used as model compounds to investigate candidate chemistries and the kinetics of deprotection. These chemistries will be applied to and evaluated with oligonucleotide primers, genomic DNA, and nucleoside triphosphates. This project will result in a new class of compounds and technology for health related applications in genomic methods such as SNP (single nucleotide polymorphism) analysis and allele-specific oligonucleotide (ASO) hybridization which are the basis of DNA microarrays, PCR amplification, and DNA sequencing applied to medical diagnostics and health related research. Commercial applications include modified nucleic acids, specialty chemicals, and new instrumentation for utilizing the technology in probe based diagnostics, health related research, and pathogen detection. Other applications include drug discovery and the study of drug response genes (pharmacogenomics), biodefense and bioterrorism where 'ruggedized' reagents may be needed, drug delivery, and therapeutics.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

10 SBIR/STTR records share this UEI (1992–2011). Reported award amounts total $2,453,699. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.